HIV Drug Injury Lawyers in Pittsburgh, PA
Helping the Victims of Corporate Negligence and Dangerous Side Effects
The pharmaceutical company Gilead created tenofovir disoproxil fumarate (TDF) as an HIV prevention drug, as well as a solution for people with HIV to manage the disease. A TDF prescription is a necessary element of treatment for people to inhibit the symptoms of HIV and live a longer, more fulfilling life. Despite the efficacy of TDF in HIV treatment, its use is associated with dangerous side effects.
Tenofovir disoproxil fumarate (TDF) was marketed under the names:
If you or a loved one was prescribed any TDF drugs and suffered from severe side effects, Robert Peirce & Associates, P.C. is available to discuss your case. Our Pittsburgh HIV drug injury attorneys are committed to representing the victims of Gilead’s negligence.
To schedule a free consultation, use our contact form or call (844) 383-0565.
TDF Causes Kidney Disease and Bone Density Issues
The use of TDF can cause kidney disease and bone conditions in patients. Individuals who regularly used TDF drugs may suffer from symptoms such as high blood pressure, swelling, loss of appetite, fatigue, pain, and bone fractures.
Injuries that can result from the use of TDF drugs include:
- Low kidney function requiring dialysis
- Low kidney function
- High creatinine levels
- Abnormal glomerular filtration rate
- Bone fractures or bone weakening
- Bone density loss, bone demineralization, or weakening of the bones
- Chronic kidney disease
- Renal failure requiring dialysis
- Renal failure and hospitalizations
- Death due to renal failure
- Abnormal protein levels in the urine
- Fanconi syndrome/proximal renal tubule dysfunction
Around the same time that TDF was being developed, Gilead was creating a similar drug: Tenofovir alafenamide fumarate, or TAF. TAF does not create the same severe side effects as TDF, and is more effective at preventing and managing HIV. However, production of TAF was halted. Meanwhile, Gilead began including warning labels on their TDF drugs.
TAF development did not continue until 2010 — nine years after initial research began. Gilead was able to gain maximum profits from the sale of TDF, and withheld the release of TAF until 2015 in anticipation of their TDF patent expiring.
Free Consultations Available 24/7
At Robert Peirce & Associates, P.C., our HIV drug injury lawyers in Pittsburgh are investigating the risks associated with the use of TDF drugs, as well as Gilead’s role in hiding those risks from the public. We understand the devastating impact that the pharmaceutical company’s negligence has had on vulnerable patients, and are dedicated to recovering compensation for those damages.
We are available 24/7 to discuss the details of your case. Call us at (844) 383-0565 or send us a message to reach our legal team.